MEPOLIZUMAB | B125526 | GLAXOSMITHKLINE LLC
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Nov. 4, 2027 | Active | Computed |
| 7-Year Orphan | Sep. 25, 2027 | Active | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12297501(diagnostic) · relevance 70/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
17 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.